Showing results (121-130 of 292) with videos related to

Sort By:
Pageof 30
Applied Health Economics and Health Policy|September 1, 2010
Issues surrounding orphan disease and orphan drug policies in EuropeAlain Denis, Lut Mergaert, Christel Fostier, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 23, 2018
Nanomedicines: The magic bullets reaching their target?Beat Flühmann, Ioanna Ntai, Gerrit Borchard, et al.
Frontiers in Pharmacology|April 20, 2017
Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the FutureKim Pauwels, Isabelle Huys, Sabine Vogler, et al.
Frontiers in Pharmacology|January 2, 2023
Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysisTeresa Barcina Lacosta, Arnold G Vulto, Isabelle Huys, et al.
Health Policy (Amsterdam, Netherlands)|August 31, 2010
A comparative study of European rare disease and orphan drug marketsAlain Denis, Lut Mergaert, Christel Fostier, et al.
The International Journal of Pharmacy Practice|July 9, 2013
Drug substitution associated with a hospital stay in Belgium: a retrospective analysis of a claims databaseSteven Simoens, Cécile Dubois, Anne Spinewine, et al.
Frontiers in Medicine|January 27, 2023
An exploration of biosimilar TNF-alpha inhibitors uptake determinants in hospital environments in Italy, Portugal, and SpainTeresa Barcina Lacosta, Arnold G Vulto, Isabelle Huys, et al.
Drug Discovery Today|August 24, 2025
Advanced therapy medicinal products are coming of age: A pipeline analysis of the clinical trial landscapeMichiel Vanhaeren, Rik Gijsbers, Walter Van Dyck, et al.
Tropical Medicine & International Health : TM & IH|October 2, 2015
Mortality in adult immigrants in the 2000s in Belgium: a test of the 'healthy-migrant' and the 'migration-as-rapid-health-transition' hypothesesHadewijch Vandenheede, Didier Willaert, Hannelore De Grande, et al.
Frontiers in Pharmacology|December 28, 2020
Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative TherapiesSissel Michelsen, Salma Nachi, Walter Van Dyck, et al.
Pageof 30